Tranexamic Acid Use
Tranexamic Acid Use is a pharmacological intervention involving the administration of tranexamic acid, a synthetic antifibrinolytic agent, to reduce maternal morbidity and mortality by preventing the breakdown of blood clots in the management of postpartum hemorrhage.
1.7K
Publications
93.6K
Citations
8.6K
Authors
2.2K
Institutions
Publications per year
2017–2026
788
1.7K
Haleema Shakur‐Still, Ian Roberts, Bukola Fawole et al. · The Lancet · 2017 · 1.4K citations · Full text
1–5 of 1.7K
8.6K
London School of Hygiene & Tropical Medicine, United Kingdom
43 publications · 9.8K citations
25
h-index
London School of Hygiene & Tropical Medicine, United Kingdom
32 publications · 7.1K citations
21
h-index
18
h-index
13
h-index
12
h-index
1–5 of 8.6K
2.2K

Sichuan University
Chengdu, China
31 h-index
271 publications
13.5K citations
London School of Hygiene & Tropical Medicine
London, United Kingdom
25 h-index
202 publications
83.3K citations
West China Hospital of Sichuan University
Chengdu, China
24 h-index
142 publications
6.3K citations

University of Toronto
Toronto, Canada
21 h-index
122 publications
14.5K citations

University of London
London, United Kingdom
20 h-index
92 publications
6.8K citations
Mayo Clinic
Rochester, United States
20 h-index
103 publications
7.3K citations
Inserm
Paris, France
19 h-index
62 publications
4.8K citations

Hospital for Special Surgery
New York, United States
17 h-index
107 publications
6.7K citations
1–8 of 2.2K
80 publications · 5.8K citations
45
h-index
Repository · 90 publications · 2.6K citations
29
h-index
32 publications · 3.7K citations
28
h-index
JBJS · 31 publications · 2.6K citations
26
h-index
21 publications · 683 citations
18
h-index
1–5